End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56.37 CNY | -0.30% | +3.68% | -13.61% |
Apr. 19 | Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Jianmin Pharma Gets Nod to Market Asthma Drug | MT |
Sales 2024 * | 4.93B 681M | Sales 2025 * | 5.68B 784M | Capitalization | 8.58B 1.18B |
---|---|---|---|---|---|
Net income 2024 * | 619M 85.43M | Net income 2025 * | 768M 106M | EV / Sales 2024 * | 1.74 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.51 x |
P/E ratio 2024 * |
14
x | P/E ratio 2025 * |
11.3
x | Employees | 2,497 |
Yield 2024 * |
2.77% | Yield 2025 * |
3.39% | Free-Float | 69.14% |
1 day | -0.30% | ||
1 week | +3.68% | ||
Current month | -2.42% | ||
1 month | +5.56% | ||
3 months | +6.14% | ||
6 months | -1.35% | ||
Current year | -13.61% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 48 | 20-09-08 |
Zhao Yang Cheng
DFI | Director of Finance/CFO | 52 | 18-01-01 |
Qin He
CHM | Chairman | 64 | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qin He
CHM | Chairman | 64 | 03-12-31 |
Shu Qu Li
BRD | Director/Board Member | 53 | 19-09-04 |
Si Yang Wang
BRD | Director/Board Member | 37 | 11-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 56.37 | -0.30% | 2,662,781 |
24-04-23 | 56.54 | +4.43% | 4,142,820 |
24-04-22 | 54.14 | -4.63% | 5,405,930 |
24-04-19 | 56.77 | +3.67% | 2,844,647 |
24-04-18 | 54.76 | +0.72% | 2,309,294 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.61% | 1.18B | |
+23.58% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.96% | 219B | |
+6.39% | 199B | |
-9.82% | 196B | |
-8.75% | 149B | |
-5.21% | 146B |
- Stock Market
- Equities
- 600976 Stock